219 related articles for article (PubMed ID: 20124285)
1. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
Nelson GW; Freedman BI; Bowden DW; Langefeld CD; An P; Hicks PJ; Bostrom MA; Johnson RC; Kopp JB; Winkler CA
Hum Mol Genet; 2010 May; 19(9):1805-15. PubMed ID: 20124285
[TBL] [Abstract][Full Text] [Related]
2. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
[TBL] [Abstract][Full Text] [Related]
3. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
Kopp JB; Smith MW; Nelson GW; Johnson RC; Freedman BI; Bowden DW; Oleksyk T; McKenzie LM; Kajiyama H; Ahuja TS; Berns JS; Briggs W; Cho ME; Dart RA; Kimmel PL; Korbet SM; Michel DM; Mokrzycki MH; Schelling JR; Simon E; Trachtman H; Vlahov D; Winkler CA
Nat Genet; 2008 Oct; 40(10):1175-84. PubMed ID: 18794856
[TBL] [Abstract][Full Text] [Related]
4. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
[TBL] [Abstract][Full Text] [Related]
5. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
6. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
Behar DM; Rosset S; Tzur S; Selig S; Yudkovsky G; Bercovici S; Kopp JB; Winkler CA; Nelson GW; Wasser WG; Skorecki K
Hum Mol Genet; 2010 May; 19(9):1816-27. PubMed ID: 20144966
[TBL] [Abstract][Full Text] [Related]
7. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
Freedman BI; Hicks PJ; Bostrom MA; Comeau ME; Divers J; Bleyer AJ; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
Nephrol Dial Transplant; 2009 Nov; 24(11):3366-71. PubMed ID: 19567477
[TBL] [Abstract][Full Text] [Related]
8. Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.
Reeves-Daniel AM; Iskandar SS; Bowden DW; Bostrom MA; Hicks PJ; Comeau ME; Langefeld CD; Freedman BI
Am J Kidney Dis; 2010 May; 55(5):e21-4. PubMed ID: 20116156
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
Freedman BI; Hicks PJ; Bostrom MA; Cunningham ME; Liu Y; Divers J; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
Kidney Int; 2009 Apr; 75(7):736-45. PubMed ID: 19177153
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
Cooke JN; Bostrom MA; Hicks PJ; Ng MC; Hellwege JN; Comeau ME; Divers J; Langefeld CD; Freedman BI; Bowden DW
Nephrol Dial Transplant; 2012 Apr; 27(4):1505-11. PubMed ID: 21968013
[TBL] [Abstract][Full Text] [Related]
11. Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.
Núñez M; Saran AM; Freedman BI
Adv Chronic Kidney Dis; 2010 Jan; 17(1):44-51. PubMed ID: 20005488
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.
Freedman BI; Kopp JB; Winkler CA; Nelson GW; Rao DC; Eckfeldt JH; Leppert MF; Hicks PJ; Divers J; Langefeld CD; Hunt SC
Am J Nephrol; 2009; 29(6):626-32. PubMed ID: 19153477
[TBL] [Abstract][Full Text] [Related]
13. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?
Kopp JB; Winkler CA; Nelson GW
Semin Nephrol; 2010 Jul; 30(4):409-17. PubMed ID: 20807613
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
[TBL] [Abstract][Full Text] [Related]
15. MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
Kao WH; Klag MJ; Meoni LA; Reich D; Berthier-Schaad Y; Li M; Coresh J; Patterson N; Tandon A; Powe NR; Fink NE; Sadler JH; Weir MR; Abboud HE; Adler SG; Divers J; Iyengar SK; Freedman BI; Kimmel PL; Knowler WC; Kohn OF; Kramp K; Leehey DJ; Nicholas SB; Pahl MV; Schelling JR; Sedor JR; Thornley-Brown D; Winkler CA; Smith MW; Parekh RS;
Nat Genet; 2008 Oct; 40(10):1185-92. PubMed ID: 18794854
[TBL] [Abstract][Full Text] [Related]
16. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
[TBL] [Abstract][Full Text] [Related]
17. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants.
Gopalakrishnan I; Iskandar SS; Daeihagh P; Divers J; Langefeld CD; Bowden DW; Hicks PJ; Rocco MV; Freedman BI
Hum Pathol; 2011 Feb; 42(2):291-4. PubMed ID: 21074826
[TBL] [Abstract][Full Text] [Related]
18. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.
Genovese G; Tonna SJ; Knob AU; Appel GB; Katz A; Bernhardy AJ; Needham AW; Lazarus R; Pollak MR
Kidney Int; 2010 Oct; 78(7):698-704. PubMed ID: 20668430
[TBL] [Abstract][Full Text] [Related]
19. The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans.
Freedman BI; Edberg JC; Comeau ME; Murea M; Bowden DW; Divers J; Alarcón GS; Brown EE; McGwin G; Kopp JB; Winkler CA; Nelson GW; Illei G; Petri M; Ramsey-Goldman R; Reveille JD; Vilá LM; Langefeld CD; Kimberly RP;
Am J Nephrol; 2010; 32(1):66-72. PubMed ID: 20523037
[TBL] [Abstract][Full Text] [Related]
20. Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation.
Winkler CA; Nelson G; Oleksyk TK; Nava MB; Kopp JB
Semin Nephrol; 2010 Mar; 30(2):111-25. PubMed ID: 20347641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
